Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors

類似資料

• Beneficial effects of combining a Type II ATP competitive inhibitor with an allosteric competitive inhibitor of Bcr-Abl for the treatment of imatinib-sensitive and imatinib resistant CML
  著者:: Weisberg, Ellen, 等
  出版事項: (2010)
• FLT3 Inhibition and Mechanisms of Drug Resistance in mutant FLT3-Positive AML
  著者:: Weisberg, Ellen, 等
  出版事項: (2009)
• Reversible resistance induced by FLT3 inhibition: a novel resistance mechanism in mutant FLT3-expressing cells.
  著者:: Ellen Weisberg, 等
  出版事項: (2011-01-01)
• Reversible Resistance Induced by FLT3 Inhibition: A Novel Resistance Mechanism in Mutant FLT3-Expressing Cells
  著者:: Weisberg, Ellen, 等
  出版事項: (2011)
• Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL– and mutant FLT3-expressing cells
  著者:: Weisberg, Ellen, 等
  出版事項: (2008)